http://orcid.org/0000-0002-0242-6959
References
- Thompson G, Klecka M, Roden AC, et al. Biopsy-proven pulmonary capillaritis: a retrospective study of aetiologies including an in-depth look at isolated pulmonary capillaritis. Respirology. 2016;21:734–738.
- Nierman DM, Kalb TH, Ornstein MH, et al. A patient with antineutrophil cytoplasmic antibody – negative pulmonary capillaritis and circulating primed neutrophils. Arthritis Rheum. 1995;38:1855–1858.
- Thompson G, Specks U, Cartin-Ceba R. Isolated pauciimmune pulmonary capillaritis successfully treated with rituximab. Chest. 2015;147:e134–e136.
- Jennings CA, King TE, Tuder R, et al. Diffuse alveolar hemorrhage with underlying isolated, pauciimmune pulmonary capillaritis. Am J Respir Crit Care Med. 1997;155:1101–1109.
- Flanagan F, Glackin L, Slattery DM. Successful treatment of idiopathic pulmonary capillaritis with intravenous cyclophosphamide. Pediatr Pulmonol. 2013;48:303–305.
- Medenica M, Medenica M. Diffuse alveolar hemorrhage in isolated pulmonary capillaritis–case report. Srp Arh Celok Lek. 2014;142:233–238.
- Rayment JH, Cutz E, Levy DM, et al. Concomitant diffuse alveolar hemorrhage and pulmonary embolism in a child with isolated pulmonary capillaritis. Annals Ats. 2017;14:470–473.
- Yates M, Watts RA, Bajema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis. 2016;75:1583–1594.
- Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol. 2016;68:1467–1476.
- Walsh M, Merkel PA, Peh CA, et al. Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial. Trials. 2013;14:73.
- Khan A, Lawson CA, Quinn MA, et al. Successful treatment of ANCA-negative Wegener’s Granulomatosis with Rituximab. Int J Rheumatol. 2010;2010:846063.
- Ooka S, Maeda A, Ito H, et al. Treatment of refractory retrobulbar granuloma with rituximab in a patient with ANCA-negative Wegener’s granulomatosis: a case report. Mod Rheumatol. 2009;19:80–83.
- Isaacs JD, Cohen SB, Emery P, et al. Effect of baseline rheumatoid factor and anticitrullinated peptide antibody serotype on rituximab clinical response: a meta-analysis. Ann Rheum Dis. 2013;72:329–336.